Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of
patients with symptomatic severe aortic stenosis, and indications are expanding towards …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Background: Identifying transcatheter aortic valve replacement (TAVR) patients at high risk
for cerebrovascular events (CVE) is of major clinical relevance. However, predictors have …

I. Introduction The anatomic and clinical complexity of patients with coronary artery disease
(CAD) is increasing in the United States. 1–3 While the terms “complex CAD” or “high-risk …

Background The impact of coronary artery disease (CAD) on outcomes after transcatheter
aortic valve replacement (TAVR) is understudied. Literature on the prognostic role of CAD in …

Aims: The impact of the severity of coronary artery disease (CAD) and percutaneous
coronary interventions (PCI) on outcomes after transcatheter aortic valve implantation (TAVI) …

Objectives: The study sought to examine the effect of coronary artery disease (CAD) on
mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background …